ReviewFrontiers in immunology2026
The multidimensional roles and mechanisms of exercise intervention in pediatric oncology.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The importance of exercise interventions in pediatric oncology is steadily increasing. Their value lies not only in alleviating treatment-related adverse effects but also in supporting physiological recovery, psychological adjustment, and improvements in cognitive function. As research continues to reveal the effects of exercise on the tumor microenvironment, immune modulation, and energy metabolism, its role in pediatric cancer care is expanding from a rehabilitative adjunct to a comprehensive intervention with potential therapeutic relevance. Exercise can enhance tumor-related biological processes by improving blood flow and tissue oxygenation, increasing immune cell activity, mitigating immunosuppression, and modulating glucose utilization and fatty acid metabolism, thereby influencing the energy supply to tumor cells. At the clinical level, exercise strengthens skeletal muscle, improves cardiopulmonary function, increases physical reserves, and reduces long-term side effects such as fatigue and frailty. It also contributes to emotional stability, strengthens self-efficacy, and ameliorates cognitive impairments including attention and memory deficits. Moreover, exercise may exert synergistic effects with chemotherapy, radiotherapy, and immunotherapy by improving treatment tolerance and amplifying overall therapeutic benefit. Despite its potential, the implementation of exercise interventions remains challenged by limited resources, variability in adherence, and age-related differences. Future research should aim to develop personalized exercise prescription systems tailored to pediatric needs, supported by interdisciplinary teams and intelligent monitoring tools to enhance feasibility and scientific rigor. With continued advances in basic research and the accumulation of clinical evidence, exercise is expected to play an increasingly systematic and sustained role in pediatric cancer treatment, providing crucial support for improving rehabilitation quality and long-term health outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.